Madrigal Pharmaceuticals (MDGL) PT Lowered to $962 at Barclays
Tweet Send to a Friend
Barclays analyst Eliana Merle lowered the price target on Madrigal Pharmaceuticals (NASDAQ: MDGL) to $962.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
